Tianjin Chase Sun Pharmaceutical Co.,Ltd.’s Net Profit Dropped 25.4% in First Quarter of 2023

Tianjin Chase Sun Pharmaceutical Co.,Ltd. (天津红日药业股份有限公司) (300026.SZ) reported a net profit of 178.8 million yuan in the first quarter of 2023, down 25.4% year-on-year.

Meanwhile, the company posted 1.7 billion yuan in revenue, down 4.2% year-on-year.

At the end of the reporting period, it had 12.6 billion yuan in total assets and 4 billion yuan in total liabilities, with a liability-to-asset ratio of 31.5%.